Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 949-951

  Fellay, J ^a   Venetz, J P ^a   Aubert, J D ^a   Seydoux, C ^a   Pascual, M ^a   Meylan, P R A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALACICLOVIR; VALGANCICLOVIR; VIRUS DNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; BLOOD CULTURE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LUNG TRANSPLANTATION; MALE; MICROBIOLOGY; NONHUMAN; ORGAN TRANSPLANTATION; PANCYTOPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; VIREMIA;

EID: 17844401518     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.11.066     Document Type: Conference Paper

References (12)

1. J.A. Fishman, R.H. Rubin Infection in organ-transplant recipients N Engl J Med 338 1998 1741
2. M.D. Pescovitz, J. Rabkin, R.M. Merion Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients Antimicrob Agents Chemother 44 2000 2811
3. P. Reusser Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts Expert Opin Investig Drugs 10 2001 1745
4. C. Paya, A. Humar, E. Dominguez Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients Am J Transplant 4 2004 611
5. D.F. Martin, J. Sierra-Madero, S. Walmsley A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis N Engl J Med 346 2002 1119
6. P. Ljungman, P. Griffiths, C. Paya Definitions of cytomegalovirus infection and disease in transplant recipients Clin Infect Dis 34 2002 1094
7. M.A. Jacobson Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome N Engl J Med 337 1997 105
8. G. Boivin, N. Goyette, C. Gilbert Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients J Infect Dis 189 2004 1615
9. V.C. Emery, A.V. Cope, E.F. Bowen The dynamics of human cytomegalovirus replication in vivo J Exp Med 190 1999 177
10. N. Babel, L. Gabdrakhmanova, J.S. Juergensen Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients: a single center experience Transplantation 78 2004 283
11. C. Muheim, G. Vogel, C. Seydoux Determinants of protracted cytomegalovirus infection in solid-organ transplant patients Transplantation 74 2002 226
12. A.P. van den Berg, W.J. van Son, E.B. Haagsma Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients Transplantation 55 1993 847